Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-054319
Filing Date
2020-10-08
Accepted
2020-10-08 18:17:51
Documents
1
Period of Report
2020-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5587
  Complete submission text file 0001209191-20-054319.txt   6955
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341
Business Address
Widlitz Michael (Reporting) CIK: 0001826907 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 201231722